How to Treat Central Sleep Apnea in 2025
An AASM guideline update reopens the door to ASV, adds transvenous phrenic nerve stimulation, and shifts success metrics beyond the AHI.
Tag: Remede
All
Latest
All
Latest
Advances in Neurostimulator Technology Ease Utilization for Sleep Patients
Recently unveiled advances in implanted neurostimulators open the doors for more patients and providers to use the devices to treat their sleep apnea.
All
LatestSorry, No Posts Found
Highmark Adds Coverage for Remedē System in Patients with Central Sleep Apnea
Highmark Blue Cross Blue Shield and its affiliates will provide coverage for the Respicardia Inc’s remedē System implantable therapy for central sleep apnea, effective immediately.
Read MoreFirst Patient Enrolls in Central Sleep Apnea Trial to Assess Alternative Transvenous Lead Location for Remedē Implant
The trial seeks to explore whether transvenous stimulation can improve airway physiology.
Read More
Remedē Shows Sustained Safety & Efficacy Through 5 Years
Highlights from the 5-year data show sustained improvements that were consistent with the published 6-, 12-, 24-, and 36-month results.
Read More
Why I Choose Neurostimulators for Some of My Sleep Apnea Patients
Physicians who use Inspire upper airway stimulation, Respicardia’s remedē, and Avery’s diaphragm pacemaker share their stories.
Read More